CLVR vs. OBSV, LIXT, ASLN, PULM, TFFP, KTTA, CANF, CYCN, EFTR, and CMMB
Should you be buying Clever Leaves stock or one of its competitors? The main competitors of Clever Leaves include ObsEva (OBSV), Lixte Biotechnology (LIXT), ASLAN Pharmaceuticals (ASLN), Pulmatrix (PULM), TFF Pharmaceuticals (TFFP), Pasithea Therapeutics (KTTA), Can-Fite BioPharma (CANF), Cyclerion Therapeutics (CYCN), eFFECTOR Therapeutics (EFTR), and Chemomab Therapeutics (CMMB). These companies are all part of the "pharmaceutical preparations" industry.
ObsEva (NASDAQ:OBSV) and Clever Leaves (NASDAQ:CLVR) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, profitability, community ranking, valuation, dividends and risk.
Clever Leaves has lower revenue, but higher earnings than ObsEva. Clever Leaves is trading at a lower price-to-earnings ratio than ObsEva, indicating that it is currently the more affordable of the two stocks.
In the previous week, ObsEva and ObsEva both had 1 articles in the media. Clever Leaves' average media sentiment score of 0.00 equaled ObsEva'saverage media sentiment score.
ObsEva has a net margin of 0.00% compared to ObsEva's net margin of -102.77%. ObsEva's return on equity of -63.32% beat Clever Leaves' return on equity.
ObsEva received 306 more outperform votes than Clever Leaves when rated by MarketBeat users. However, 81.25% of users gave Clever Leaves an outperform vote while only 53.79% of users gave ObsEva an outperform vote.
17.5% of ObsEva shares are held by institutional investors. Comparatively, 6.9% of Clever Leaves shares are held by institutional investors. 14.4% of ObsEva shares are held by insiders. Comparatively, 8.2% of Clever Leaves shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
ObsEva has a beta of 0.68, suggesting that its stock price is 32% less volatile than the S&P 500. Comparatively, Clever Leaves has a beta of 1.54, suggesting that its stock price is 54% more volatile than the S&P 500.
Summary
ObsEva beats Clever Leaves on 7 of the 13 factors compared between the two stocks.
Get Clever Leaves News Delivered to You Automatically
Sign up to receive the latest news and ratings for CLVR and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CLVR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Clever Leaves Competitors List
Related Companies and Tools
